HLA Class II Polymorphism Contributes to Specify Desmoglein Derived Peptides in Pemphigus Vulgaris and Pemphigus Foliaceus

The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile

Masayuki Amagai, Kazuyuki Tsunoda, Detlef Zillikens et al. · Journal of the American Academy of Dermatology · 1999 · 418 citations

Life Sciences, Pathobiology, Pathology +9

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

Juergen Hammer, Fabio Gallazzi, Elisa Bono et al. · The Journal of Experimental Medicine · 1995 · 309 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.

Kai W. Wucherpfennig, Borou Yu, Kailash C. Bhol et al. · Proceedings of the National Academy of Sciences · 1995 · 248 citations

Life Sciences, Dermatology, Immunology +17

Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.

Mingxiang Lin, Susan J. Swartz, Angel F. López et al. · Journal of Clinical Investigation · 1997 · 177 citations · Full text

Life Sciences, Dermatology, Immunology +17

Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris.

A. R. Ahmed, Richard Wagner, Khalil A. Khatri et al. · Proceedings of the National Academy of Sciences · 1991 · 169 citations

Life Sciences, Genetics, Immunology +17